Commonwealth Equity Services, LLC Spectrum Pharmaceuticals Inc Transaction History

Commonwealth Equity Services, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$0.63 - $1.59 $6,835 - $17,251	-10,850 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$2.15 - $3.82 $23,327 - $41,447	10,850 New	10,850 $23,000
Q2 2019 Jul 19, 2019	SELL	$7.36 - $11.26 $101,936 - $155,951	-13,850 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$6.39 - $16.99 $1,917 - $5,096	300 Added 2.21%	13,850 $121,000
Q3 2018 Nov 06, 2018	SELL	$16.52 - $24.82 $1,652 - $2,482	-100 Reduced 0.73%	13,550 $227,000
Q2 2018 Jul 31, 2018	BUY	$14.31 - $21.75 $31,482 - $47,850	2,200 Added 19.21%	13,650 $286,000
Q1 2018 May 14, 2018	BUY	$16.09 - $23.07 $184,230 - $264,151	11,450 New	11,450 $184,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.